c-Abl Inhibitors

Santa Cruz Biotechnology now offers a broad range of c-Abl Inhibitors. c-Abl is an oncogene, initially identified as the viral transforming gene of Abelson murine leukemia virus (A-MuLV). c-Abl is implicated in several human leukemias including 90-95% of chronic myelocytic leukemia, 20-25% of adult acute lymphoblastic leukemia and 2-5% of pediatric acute lymphoblastic leukemia. c-Abl Inhibitors offered by Santa Cruz inhibit c-Abl and, in some cases, other cell signaling and leukemia related proteins. View detailed c-Abl Inhibitor specifications, including c-Abl Inhibitor CAS number, molecular weight, molecular formula and chemical structure, by clicking on the product name.